Neutral
Pfizer's stock price rises to $28.40 amid job cuts and analyst upgrades
Pfizer's stock price increased to $28.40 following recent developments, including the announcement of job cuts in Italy and analyst upgrades. The company plans to reduce approximately 330 positions at its Sicily plant, a move that aligns with its ongoing cost optimization efforts. Additionally, Scotiabank raised Pfizer's price target to $33 from $30, maintaining an Outperform rating, citing the company's strong pipeline and strategic initiatives.
Key points
- Pfizer's stock price rises to $28.40 amid job cuts and analyst upgrades.
- Pfizer to cut around 330 jobs in Italy at Sicily plant.
- Scotiabank raises Pfizer's price target to $33 from $30, maintains Outperform rating.
Sources
AI-generated from public news sources. Not financial advice.
